Belite Bio (BLTE) Total Current Liabilities (2021 - 2025)

Belite Bio has reported Total Current Liabilities for 5 years, with the latest figure at $9.9 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 63.34% year-over-year to $9.9 million; the trailing twelve-month figure through Dec 2025 stood at $9.9 million (up 63.34% YoY), and the FY2025 full-year result was $9.9 million, up 63.34% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $9.9 million, up from $6.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $9.9 million in Q4 2025, with the low at $1.6 million in Q4 2021.
• Average Total Current Liabilities over 5 years is $4.7 million, with a median of $3.6 million recorded in 2023.
• Year-over-year, Total Current Liabilities rose 28.69% in 2022 and jumped 72.67% in 2023.
• Tracing BLTE's Total Current Liabilities over 5 years: stood at $1.6 million in 2021, then climbed by 28.69% to $2.1 million in 2022, then jumped by 72.67% to $3.6 million in 2023, then surged by 66.53% to $6.0 million in 2024, then jumped by 63.34% to $9.9 million in 2025.
• The last three Total Current Liabilities figures came in at $9.9 million (Q4 2025), $6.0 million (Q4 2024), and $3.6 million (Q4 2023), per Business Quant data.

Peer Comparison